MMP9 and neuroblastoma: In addition, MMP-9, TIMP-1, and VMA were related to the 2-year survival of patients, which further provided evidence for the monitoring of therapeutic effect on NB patients by using MMP-9 and TIMP-1 [8, 9, 14].